Page 4 - Sanket Koul

IITs see strong recruiter rush on Day 1 as top firms roll out big offers

Day 1 of IIT placements saw a surge of top recruiters, with NVIDIA, Amazon, Zomato, Google and Flipkart among those offering high-value roles, as more students opted for final placements over PPOs

PMJAY for 70+ logged 700k treatments worth ₹1,471 crore in first year

Centre to ramp up awareness, with 15% of the 60 million senior citizen target covered, even as experts flag budgetary issues, slow pace

CDSCO committee considers avoiding high-risk solvents in kids' oral drugs

Move follows reports of deaths from contaminated cough syrups in Chhindwara

Mount K Kapital raises 2nd realty fund worth ₹4K cr, to expand beyond MMR

The seven-year credit fund will back 10-15 projects across major cities, building on the firm's first Rs 790 crore vehicle

HDFC Capital, Hero Realty set up ₹1K cr platform for mid-income housing

HDFC Capital has tied up with Hero Realty to build a Rs 1,000 crore mid-income housing platform aimed at accelerating development across Tier 1 and Tier 2 cities

CDSCO panel seeks uniform enforcement of drug standards across states

The DCC has asked the Centre to address gaps in drug-standard enforcement, write to states on non-uniform norms and improve testing and regulatory infrastructure highlighted under the SHRESTH index

Affordable homes lose investor appeal as luxury delivers higher returns

With luxury home prices rising faster than affordable units and branded developers driving demand in prime locations, investors are shifting towards premium and luxury housing

Eris Lifesciences to acquire 30% stake in Swiss Parenterals for ₹423 cr

Eris Lifesciences will purchase the final 30% stake in Swiss Parenterals through a Rs 423-crore share swap, aiming for full consolidation, greater cost efficiency and strengthened strategic control

Central Park to invest ₹2,000 cr in luxury residential project in Gurugram

People in the know told Business Standard that the ticket prices for the studio apartments would range between Rs 3 crore and Rs 5 crore, while that for 3 and 4 BHK apartments would be ₹11 cr, ₹15 cr

Labour codes: Real estate expects up to 10% spike in baseline labour cost

Developers expect short-term cost and timeline pressures, but say unified labour laws will bring predictability, better compliance and steadier workforce availability

ATS HomeKraft provides ₹1,250 cr exit to HDFC Capital's HCARE-2 fund

The ATS group developer cleared dues to HCARE-2 entirely through project cash flows, highlighting strong demand and healthier balance sheets in mid-income housing

MNC drugmakers push for 10-year exclusivity period for trial data

First entities' data filed for novel drugs needs protection: OPPI

Drug regulator mandates CDSCO licensing on medical device procurement

The regulator told states not to demand USFDA or EU approvals in tenders after complaints that Indian-made devices were being sidelined

SC's green clearance ruling recall could push ahead stalled projects

Move to give relief to thousands of homebuyers and developers

Mankind Pharma inks licencing pact with Actimed for cachexia treatment

Mankind Pharma has entered a licensing agreement with Actimed Therapeutics to develop and commercialise cachexia treatment products across India and neighbouring South Asian markets

NCDC refutes Lancet AMR study, says high colonisation not infection risk

The NCDC challenged a Lancet study on high MDRO colonisation in Indian ERCP patients, stating colonisation infection and India's drug-resistant infection rates are still relatively low

Serum Institute, CSIR sign pact to produce affordable gene therapy for SCD

CSIR-IGIB and Serum Institute of India have partnered to transfer indigenous CRISPR-based technology that could cut sickle cell gene therapy costs from crores to a fraction

Budget: Nathealth asks for ₹50k cr infra fund, tax SOPs for health checkups

Innovation fund for deep tech collabs, setting up of labs and 100% deduction on capex under section 35 AD of IT Act among key demands

Khan Market 24th most expensive high-street retail location globally

India's high-street retail markets recorded steady rent growth in 2025, driven by premiumisation, limited supply and strong demand in major cities, Cushman & Wakefield said

Centre launches 2nd national action plan to combat antimicrobial resistance

The new plan attempts to plug gaps identified during the implementation of the first NAP-AMR (2017-21)